Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: VTR stock price vs OHI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OHI's multiple
Needs OHI P/E.
Implied fair value · at VTR's multiple
Needs VTR P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Ten period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Ventas, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
OMEGA HEALTHCARE INVESTORS, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe VTR can materially compress its Net Debt/EBITDA toward OHI levels (from 8.3x closer to OHI's 3.7x) and meaningfully improve margins (narrowing the Net Margin gap vs OHI), then consider accumulation because a re-rating toward OHI multiples could justify a higher price; otherwise, avoid initiating new longs or consider reducing exposure because VTR currently trades near its historical band while earnings- and leverage-adjusted OHI valuation implies substantial downside.
VTR's implied P/E-based price ($12.89) is far below the current market price ($84.44), implying an -84.7% downside to the P/E-derived valuation; the gap is driven by a very high VTR P/E (156.4x) versus OHI (23.9x) and elevated EV/EBITDA for VTR. The market price sits inside VTR's historical band ($76.00 - $92.88), indicating the market is not pricing OHI-implied downside.
Supporting Metrics
